You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 15, August 12, 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •End-of-life Care/ Palliative Medicine
 •Alert me on articles by topic

Managed Care, Hospice Use, Site of Death, and Medical Expenditures in the Last Year of Life

Ezekiel J. Emanuel, MD, PhD; Arlene Ash, PhD; Wei Yu, PhD; Gail Gazelle, MD; Norman G. Levinsky, MD; Olga Saynina, MBA; Mark McClellan, MD, PhD; Mark Moskowitz, MD

Arch Intern Med. 2002;162:1722-1728.

Background  We examined deaths of Medicare beneficiaries in Massachusetts and California to evaluate the effect of managed care on the use of hospice and site of death and to determine how hospice affects the expenditures for the last year of life.

Methods  Medicare data for beneficiaries in Massachusetts (n = 37 933) and California (n = 27 685) who died in 1996 were merged with each state's death certificate files to determine site and cause of death. Expenditure data were Health Care Financing Administration payments and were divided into 30-day periods from the date of death back 12 months.

Results  In Massachusetts, only 7% of decedents were enrolled in managed care organizations (MCOs); in California, 28%. More than 60% of hospice users had cancer. Hospice use was much lower in Massachusetts than in California (12% vs 18%). In both states, decedents enrolled in MCOs used hospice care much more than those enrolled in fee-for-service plans (17% vs 11% in Massachusetts and 25% vs 15% in California). This pattern persisted for those with cancer and younger (aged 65-74 years) decedents. Decedents receiving hospice care were significantly (P<.001 for both) less likely to die in the hospital (11% vs 43% in Massachusetts and 5% vs 43% in California). Enrollment in MCOs did not affect the proportion of in-hospital deaths (those enrolled in fee-for-service plans vs MCOs: 40% vs 39% in Massachusetts; and 37% vs 34% in California). Expenditures in the last year of life were $28 588 in Massachusetts and $27 814 in California; about one third of the expenditures occurred in the last month before death. Hospital services accounted for more than 50% of all expenditures in both states, despite 77% of decedents being hospitalized in Massachusetts and just 55% being hospitalized in California. Among patients with cancer, expenditures were 13% to 20% lower for those in hospice.

Conclusions  Medicare-insured decedents in California were more than 4 times more likely to be enrolled in MCOs, were 50% more likely to use a hospice, and had a 30% lower hospitalization rate than decedents in Massachusetts, yet there are few differences in out-of-hospital deaths or expenditures in the last year of life. However, patients with cancer using hospice did have significant savings.


From the Department of Clinical Bioethics, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Md (Dr Emanuel); the Health Care Research Unit, Section of General Internal Medicine (Drs Ash, Yu, and Moskowitz), and the Department of Medicine (Drs Ash, Levinsky, and Moskowitz), Boston University School of Medicine, Boston, Mass; the Palliative and Supportive Medicine Program, Harvard Vanguard Medical Associates, Boston (Dr Gazelle); and the National Bureau of Economic Research, Palo Alto, Calif (Ms Saynina and Dr McClellan). Dr Yu is now with Health Services Research and Development Field Program and the Cooperative Studies Program, US Department of Veterans Affairs and Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, Stanford, Calif.
Dr Moskowitz died September 1, 2001.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Debate in Hospice Care
J Oncol Pract 2008;4:153-157.
FULL TEXT  

Characterizing Hospice Services in the United States
Smith et al.
Gerontologist 2008;48:25-31.
ABSTRACT | FULL TEXT  

The Cost of Home Hospice Care for Terminal Patients in Israel
Shnoor et al.
AM J HOSP PALLIAT CARE 2007;24:284-290.
ABSTRACT  

Operational and Financial Performance of Newly Established Hospices
McCue and Thompson
AM J HOSP PALLIAT CARE 2006;23:259-266.
ABSTRACT  

Shelter-based palliative care for the homeless terminally ill
Podymow et al.
Palliat Med 2006;20:81-86.
ABSTRACT  

Cardiovascular Risk Profile Earlier in Life and Medicare Costs in the Last Year of Life
Daviglus et al.
Arch Intern Med 2005;165:1028-1034.
ABSTRACT | FULL TEXT  

Resurrecting Treatment Histories of Dead Patients: A Study Design That Should Be Laid to Rest
Bach et al.
JAMA 2004;292:2765-2770.
ABSTRACT | FULL TEXT  

Place Of Death: U.S. Trends Since 1980
Flory et al.
Health Aff (Millwood) 2004;23:194-200.
ABSTRACT | FULL TEXT  

Medicare Program Expenditures Associated with Hospice Use
Campbell et al.
ANN INTERN MED 2004;140:269-277.
ABSTRACT | FULL TEXT  

Hospice Use Among Medicare Managed Care and Fee-for-Service Patients Dying With Cancer
McCarthy et al.
JAMA 2003;289:2238-2245.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.